Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (6): 575-582.doi: 10.19982/j.issn.1000-6621.20230078
• Original Articles • Previous Articles Next Articles
Shang Yaomin1(), Zhou Xiaolei2, Xue Yunling3, Leng Xia1
Received:
2023-03-17
Online:
2023-06-10
Published:
2023-06-06
Contact:
Shang Yaomin
E-mail:shyusuna@163.com
Supported by:
CLC Number:
Shang Yaomin, Zhou Xiaolei, Xue Yunling, Leng Xia. Effect of microcard combined with vitamin D on the balance of CD4+ T cell subsets in initially treated patients with smear positive pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2023, 45(6): 575-582. doi: 10.19982/j.issn.1000-6621.20230078
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20230078
组别 | 性别[例(构成比,%)] | 年龄(岁, | 体质量指数 ( | 吸烟[例 (构成比,%)] | 饮酒[例 (构成比,%)] | 胸腔积液[例 (构成比,%)] | 肺空洞 (个) | |
---|---|---|---|---|---|---|---|---|
男性 | 女性 | |||||||
对照组(74例) | 39(52.70) | 35(47.30) | 41.02±2.80 | 21.13±1.56 | 27(36.49) | 11(14.86) | 18(24.32) | 47 |
微卡组(74例) | 36(48.65) | 38(51.35) | 42.01±3.51 | 21.56±1.33 | 24(32.43) | 14(18.92) | 17(22.97) | 40 |
联合组(74例) | 42(56.76) | 32(43.24) | 41.59±2.86 | 21.36±1.07 | 30(40.54) | 17(22.97) | 23(31.08) | 42 |
统计检验值 | χ2=0.976 | F=1.937 | F=1.922 | χ2=1.050 | χ2=1.586 | χ2=1.447 | - | |
P值 | 0.614 | 0.147 | 0.149 | 0.592 | 0.453 | 0.485 | - |
组别 | IFN-γ (pg/ml, | IL-4 (pg/ml, | Th1/Th2 ( | IL-17 (pg/ml, | IL-10 (pg/ml, | Th17/Treg ( |
---|---|---|---|---|---|---|
健康组(222例) | 32.07±5.33 | 21.82±3.64 | 2.34±0.48 | 10.15±1.86 | 22.37±2.41 | 0.50±0.11 |
PTB组(222例) | 9.48±2.08 | 50.28±5.07 | 1.55±0.30 | 35.23±3.89 | 70.31±8.28 | 0.11±0.02 |
t值 | 58.828 | 67.941 | 20.795 | 86.665 | 82.830 | 51.974 |
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
组别 | IFN-γ(pg/ml, | IL-4(pg/ml, | Th1/Th2( | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t值 | P值 | 治疗前 | 治疗后 | t值 | P值 | 治疗前 | 治疗后 | t值 | P值 | |
对照组 | 9.15± 2.37 | 12.34± 1.73 | 9.352 | 0.000 | 50.41± 5.07 | 38.89± 2.16 | 17.982 | 0.000 | 1.51± 0.32 | 2.08± 0.37 | 10.023 | 0.000 |
微卡组 | 9.68± 2.02 | 14.16± 3.45 | 9.640 | 0.000 | 50.21± 5.06 | 37.23± 1.78 | 20.816 | 0.000 | 1.55± 0.21 | 2.19± 0.25 | 12.941 | 0.000 |
联合组 | 9.61± 1.95 | 16.13± 2.67 | 16.964 | 0.000 | 50.22± 5.09 | 36.54± 2.01 | 21.504 | 0.000 | 1.59± 0.28 | 2.32± 0.39 | 13.080 | 0.000 |
F值 | 1.363 | 36.221 | 0.037 | 27.283 | 1.579 | 9.116 | ||||||
P值 | 0.258 | 0.000 | 0.964 | 0.000 | 0.208 | 0.000 | ||||||
t值a | 1.464 | 4.057 | 0.240 | 5.102 | 0.899 | 2.119 | ||||||
P值 | 0.145 | 0.000 | 0.811 | 0.000 | 0.370 | 0.036 | ||||||
t值b | 1.289 | 10.248 | 0.228 | 6.851 | 1.798 | 3.840 | ||||||
P值 | 0.199 | 0.000 | 0.820 | 0.000 | 0.074 | 0.000 | ||||||
t值c | 0.214 | 3.885 | 0.012 | 2.211 | 0.983 | 2.414 | ||||||
P值 | 0.830 | 0.000 | 0.990 | 0.029 | 0.327 | 0.017 |
组别 | IL-17(pg/ml, | IL-10(pg/ml, | Th17/Treg( | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t值 | P值 | 治疗前 | 治疗后 | t值 | P值 | 治疗前 | 治疗后 | t值 | P值 | |
对照组 | 35.17± 4.16 | 29.40± 3.27 | 9.380 | 0.000 | 71.39± 8.25 | 50.24± 4.22 | 19.634 | 0.000 | 0.10± 0.04 | 0.26± 0.02 | 30.777 | 0.000 |
微卡组 | 34.66± 4.34 | 28.43± 2.16 | 11.055 | 0.000 | 69.68± 6.95 | 43.58± 4.06 | 38.341 | 0.000 | 0.12± 0.08 | 0.34± 0.03 | 22.150 | 0.000 |
联合组 | 35.86± 3.74 | 27.10± 3.58 | 14.555 | 0.000 | 69.86± 8.29 | 35.46± 3.84 | 32.390 | 0.000 | 0.11± 0.03 | 0.45± 0.03 | 68.938 | 0.000 |
F值 | 1.606 | 10.510 | 1.059 | 248.000 | 2.494 | 918.300 | ||||||
P值 | 0.203 | 0.000 | 0.350 | 0.000 | 0.085 | 0.000 | ||||||
t值a | 0.730 | 2.129 | 1.364 | 9.783 | 1.924 | 19.087 | ||||||
P值 | 0.467 | 0.035 | 0.175 | 0.000 | 0.056 | 0.000 | ||||||
t值b | 1.061 | 4.732 | 1.220 | 22.284 | 1.720 | 45.331 | ||||||
P值 | 0.290 | 0.000 | 0.224 | 0.000 | 0.087 | 0.000 | ||||||
t值c | 1.802 | 2.736 | 0.143 | 12.499 | 1.007 | 22.303 | ||||||
P值 | 0.074 | 0.007 | 0.886 | 0.000 | 0.316 | 0.000 |
组别 | 例数 | 病灶[例(构成比,%)] | 空洞[个(构成比,%)] | |||||||
---|---|---|---|---|---|---|---|---|---|---|
吸收 | 明显吸收 | 不变 | 恶化 | 总个数 | 闭合 | 缩小 | 不变 | 增大 | ||
对照组 | 74 | 23(31.08) | 35(47.30) | 12(16.22) | 4(5.40) | 47 | 13(27.66) | 27(57.44) | 6(12.77) | 1(2.13) |
微卡组 | 74 | 30(40.54) | 32(43.24) | 11(14.86) | 1(1.35) | 40 | 23(57.50) | 15(37.50) | 2(5.00) | 0(0.00) |
联合组 | 74 | 40(54.05) | 28(37.84) | 6(8.11) | 0(0.00) | 42 | 30(71.43) | 12(28.57) | 0(0.00) | 0(0.00) |
χ2值a | 2.902 | 8.699 | ||||||||
P值 | 0.407 | 0.034 | ||||||||
χ2值b | 11.365 | 19.270 | ||||||||
P值 | 0.010 | 0.000 | ||||||||
χ2值c | 4.166 | 3.211 | ||||||||
P值 | 0.244 | 0.201 |
[1] | 莫晨玲, 马秀珍, 李沛军. 肺结核患者外周血Th17/Treg的表达及其病理意义. 现代免疫学, 2020, 40(5):58-61. |
[2] |
Li L, Jiang Y, Lao S, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-gamma+CD4+ T Cells Are Regulated by IL-12. PLoS One, 2016, 11(1):e147356. doi:10.1371/journal.pone.0147356.
doi: 10.1371/journal.pone.0147356 |
[3] |
刘礼亲, 徐祖辉, 黄移生, 等. 微卡免疫干预辅助治疗初治涂阴肺结核4个月治疗方案的疗效研究. 中国防痨杂志, 2022, 44(2):125-130. doi:10.19982/j.issn.1000-6621.20210563.
doi: 10.19982/j.issn.1000-6621.20210563 |
[4] |
崔丹, 冯秀莉, 李志惠, 等. 利奈唑胺与微卡联用对耐多药肺结核的免疫功能影响及临床疗效分析. 解放军预防医学杂志, 2020, 38(6):61-63. doi:10.13704/j.cnki.jyyx.2020.06.024.
doi: 10.13704/j.cnki.jyyx.2020.06.024 |
[5] |
翟云霞, 胥萍, 赵静, 等. 结核患者外周血25-羟基维生素D的表达与免疫细胞亚群相关性. 中国热带医学, 2020, 20(11):1053-1056. doi:10.13604/j.cnki.46-1064/r.2020.11.07.
doi: 10.13604/j.cnki.46-1064/r.2020.11.07 |
[6] |
Ganmaa D, Uyanga B, Zhou X, et al. Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease. N Engl J Med, 2020, 383(4):359-368. doi:10.1056/NEJMoa1915176.
doi: 10.1056/NEJMoa1915176 URL |
[7] |
高孟秋. 《WS 288—2017肺结核诊断》新标准中关于临床诊断患者判定的解析. 中国防痨杂志, 2018, 40(3):243-246. doi:10.3969/j.issn.1000-6621.2018.03.005.
doi: 10.3969/j.issn.1000-6621.2018.03.005 |
[8] |
刘小秋. 我国肺结核患者治疗管理的若干意见. 中国防痨杂志, 2019, 41(9):917-919. doi:10.3969/j.issn.1000-6621.2019.09.002.
doi: 10.3969/j.issn.1000-6621.2019.09.002 |
[9] |
中华医学会. 肺结核基层诊疗指南(2018年). 中华全科医师杂志, 2019, 18(8):709-717. doi:10.3760/cma.j.issn.1671-7368.2019.08.002.
doi: 10.3760/cma.j.issn.1671-7368.2019.08.002 |
[10] |
陈少艳, 刘基铎, 肖明锋, 等. 淋巴细胞亚群检测在感染性疾病中的应用. 国际检验医学杂志, 2017, 38(2):206-208. doi:10.3969/j.issn.1673-4130.2017.02.022.
doi: 10.3969/j.issn.1673-4130.2017.02.022 |
[11] |
吴桂辉, 黄涛, 罗槑, 等. 活动性肺结核患者病情严重程度与维生素D及 T细胞亚群的相关性分析. 中华肺部疾病杂志(电子版), 2020, 13(4):510-512. doi:10.3877/cma.j.issn.1674-6902.2020.04.017.
doi: 10.3877/cma.j.issn.1674-6902.2020.04.017 |
[12] |
张萧萧, 周慧芳, 张朝霞, 等. 流式微球分析法检测血清中Th1/Th2/Th17型细胞因子的表达在肺结核病患者中的临床意义. 国际检验医学杂志, 2017, 38(2):145-147. doi:10.3969/j.issn.1673-4130.2017.02.001.
doi: 10.3969/j.issn.1673-4130.2017.02.001 |
[13] | 程涛, 伍伟玲, 黄河. 肺结核患者Th1/Th2/Treg/Th17免疫应答的临床研究. 中国医药导报, 2017, 14(26):109-112. |
[14] |
任晓亮, 李明, 巨红妹, 等. 围术期异体输血对肺癌患者Th1/Th2,Th17/Treg细胞因子失衡的影响. 现代中西医结合杂志, 2017, 26(15):1601-1603,1606. doi:10.3969/j.issn.1008-8849.2017.15.002.
doi: 10.3969/j.issn.1008-8849.2017.15.002 |
[15] |
曾汝良, 江振友. TNF-α,IFN-γ,IL-4,IL-10,IL-17在结核病患者血清中的表达及临床意义. 中国医师杂志, 2014, 16(11):1530-1532. doi:10.3760/cma.j.issn.1008-1372.2014.11.021.
doi: 10.3760/cma.j.issn.1008-1372.2014.11.021 |
[16] |
陈珣珣, 周琳, 陈志宇, 等. 微卡辅助治疗初治涂阴肺结核的超短程方案疗效评价. 广东医学, 2019, 40(10):1386-1390. doi:10.13820/j.cnki.gdyx.20185978.
doi: 10.13820/j.cnki.gdyx.20185978 |
[17] |
刘春玲, 严晓峰. 母牛分枝杆菌菌苗在结核病中的临床应用和研究进展. 新发传染病电子杂志, 2020, 5(4):274-276. doi:10.19871/j.cnki.xfcrbzz.2020.04.013.
doi: 10.19871/j.cnki.xfcrbzz.2020.04.013 |
[18] |
孙国成. 探讨微卡联用抗结核治疗耐多药肺结核的临床效果. 中国现代药物应用, 2019, 13(12):43-44. doi:10.14164/j.cnki.cn11-5581/r.2019.12.020.
doi: 10.14164/j.cnki.cn11-5581/r.2019.12.020 |
[19] |
毕占友, 郝军, 陈忠建, 等. 微卡联合化学药物治疗多耐药结核病临床疗效分析. 陕西医学杂志, 2018, 47(4):509-511. doi:10.3969/j.issn.1000-7377.2018.04.033.
doi: 10.3969/j.issn.1000-7377.2018.04.033 |
[20] |
程建强. 沙参麦冬汤联合微卡治疗肺结核患者的疗效及安全性分析. 基层医学论坛, 2021, 25(32):4680-4681. doi:10.19435/j.1672-1721.2021.32.042.
doi: 10.19435/j.1672-1721.2021.32.042 |
[21] |
邹进晶, 查干, 王有娜, 等. 1,25-二羟维生素D3对哮喘小鼠气道炎症及Th17细胞和Treg细胞的影响. 武汉大学学报(医学版), 2019, 40(6):22-27. doi:10.14188/j.1671-8852.2019.0603.
doi: 10.14188/j.1671-8852.2019.0603 |
[22] |
Afsal K, Selvaraj P, Harishankar M. 1, 25-dihydroxyvitamin D3 downregulates cytotoxic effector response in pulmonary tuberculosis. Int Immunopharmacol, 2018, 62:251-260. doi:10.1016/j.intimp.2018.07.018.
doi: S1567-5769(18)30346-1 pmid: 30032050 |
[23] |
吴桂辉, 黄涛, 罗槑, 等. 不同类型肺结核患者外周血维生素D与抗菌肽LL-37表达水平的研究. 中国防痨杂志, 2019, 41(2):190-194. doi:10.3969/j.issn.1000-6621.2019.02.013.
doi: 10.3969/j.issn.1000-6621.2019.02.013 |
[24] |
张浩, 刘爽, 皮琦, 等. 维生素D对结核病的治疗与预防研究进展. 药物流行病学杂志, 2022, 31(10):705-708. doi:10.19960/j.enki.issn1005-0698.2022.10.011.
doi: 10.19960/j.enki.issn1005-0698.2022.10.011 |
[25] |
Kim JH, Park JS, Cho YJ, et al. Low serum 25-hydroxyvitamin D level: an independent risk factor for tuberculosis? Clin Nutr, 2014, 33(6):1081-1086. doi:10.1016/j.clnu.2013.11.014.
doi: 10.1016/j.clnu.2013.11.014 pmid: 24332595 |
[26] | 童叶青, 叶建君, 侯双翼, 等. 血清维生素D水平与肺结核发病关联性的探索分析. 药物流行病学杂志, 2016, 25(12):807-810. |
[27] |
姚叶萍, 曾跃彬, 赖小丽. 维生素D和血糖水平与结核病疗效的关系研究. 中国国境卫生检疫杂志, 2021, 44(1):55-57. doi:10.16408/j.1004-9770.2021.01.015.
doi: 10.16408/j.1004-9770.2021.01.015 |
[28] |
万春辉, 杜先智. 维生素D诱导自噬对巨噬细胞清除结核分枝杆菌的作用. 中国免疫学杂志, 2015, 31(4):456-461. doi:10.3969/j.issn.1000-484X.2015.04.005.
doi: 10.3969/j.issn.1000-484X.2015.04.005 |
[29] |
Periyasamy KM, Ranganathan UD, Tripathy SP, et al. Vitamin D-A host directed autophagy mediated therapy for tuberculosis. Mol Immunol, 2020, 127:238-244. doi:10.1016/j.molimm.2020.08.007.
doi: 10.1016/j.molimm.2020.08.007 pmid: 33039674 |
[30] |
万秋, 黎友伦. 维生素D在肺结核预防及治疗中的作用. 临床肺科杂志, 2017, 22(11):2106-2109, 2129. doi:10.3969/j.issn.1009-6663.2017.11.047.
doi: 10.3969/j.issn.1009-6663.2017.11.047 |
[31] |
铁木尔·玉努斯, 热沙来提·牙合甫, 鲁丽娜. 哈密地区儿童肺结核采用维生素D辅助治疗的临床研究. 临床肺科杂志, 2019, 24(7):1285-1289. doi:10.3969/j.issn.1009-6663.2019.07.031.
doi: 10.3969/j.issn.1009-6663.2019.07.031 |
[32] |
Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc, 2012, 71(1): 50-61. doi:10.1017/S0029665111001650.
doi: 10.1017/S0029665111001650 pmid: 21849106 |
[1] | Song Ruixue, Wei Rongrong, Dong Jing, Jia Hongyan, Du Boping, Sun Qi, Xing Aiying, Li Zihui, Zhu Chuanzhi, Zhang Zongde, Pan Liping. The performance of interferon gamma-induced protein 10 mRNA detection technology in auxiliary diagnosis of tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 471-476. |
[2] | HE Yi-jun, CAO Xue-fang, GAO Lei. Interpretation of the Procedure of tuberculin skin test-interferon-gamma release assay two-step testing [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 438-441. |
[3] | Gui-hui WU,Tao HUANG,Mei LUO,Yang CAI,Wei HE,Lei CHEN. Correlation between vitamin D level and LL-37 expression in peripheral blood of different forms of active pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2019, 41(2): 190-194. |
[4] | Fei-yong RAN,Lei FU,Bin WANG,Shao-chen GUO,Yu LU,Xiao-you CHEN. Evaluation of the effect of vitamin D on adjuvant therapy in the Guinea Pig model of tuberculosis [J]. Chinese Journal of Antituberculosis, 2018, 40(5): 512-518. |
[5] | DU Wei-xin,DONG Na,CHEN Bao-wen, XU Miao, YANG Lei, LU Jin-Biao, SHEN Xiao-Bing, WANG Guo-Zhi. Immunotoxicological evaluation about new tuberculosis vaccines [J]. Chinese Journal of Antituberculosis, 2012, 34(3): 138-144. |
[6] | Sun Yan,Zhao Qingxia,He Yun,et al.. Correlation between AIDS with tuberculosis and CD4T lymphocyte count [J]. Chinese Journal of Antituberculosis, 2008, 30(5): 427-430. |
[7] | Li Yuecui1,Huang Xiaodong,Tang Shenjie.. Analysis on immunodetection results of 95 active pulmonary tuberculosis cases [J]. Chinese Journal of Antituberculosis, 2005, 27(5): 319-321. |
[8] | Xu Xuqing,Liu Beidou,Li Qun,et al.. The comparative analysis of demographic characteristics and family disease financial burden of drug-resistant tuberculosis in Zhejiang [J]. Chinese Journal of Antituberculosis, 2004, 26(6): 332-335. |
[9] | TANG Shen jie,WU Fu rong,FAN Yi hu,et al.. Detection and its clinical value of T lymphocyte subsets in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2002, 24(5): 254-257. |
[10] | SONG Xiao dong,REN Yan wei,ZHANG Hong juan,et al.. Clinical significance between T lymphocyte subgroups and prognostic situation in primary smear-positive pulmonary tubculosis patients [J]. Chinese Journal of Antituberculosis, 2002, 24(4): 185-187. |
[11] | WU Yin, ZHANG Pei-yuan ,SUN Gui-zhi,et,al.. Study on clinical application and correlation of T lymphocyte subgroup and argyrophilic proteins of the nucleolar organizer regions in patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2002, 24(4): 181-184. |
[12] | CHEN Zheng,ZHANG Li qun,MA Wei lu.. M.vaccae influence the mRNA expression of IFN-γ and IL-4 in tuberculosis mice [J]. Chinese Journal of Antituberculosis, 2001, 23(1): 9-11. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||